En
  • En English
  • De Deutsch
  • Fr Français
  • Sp Español
  • Ru Русский
  • It Italiano
  • Pt Português
  • Ua Українська
136 results

    OrientationOrientation
    PeoplePeople
    CategoryCategory
    ColorColor
    EditorialEditorial
    Safe SearchSafe Search
    Clear
    Hide
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2 — Stock Photo
    Illustration of antibodies (y-shaped) responding to an infection with the new coronavirus SARS-CoV-2
    Immune system T-lymphocytes cells binding antigen, digital illustration. — Stock Photo
    Immune system T-lymphocytes cells binding antigen, digital illustration.
    Illustration of a neutrophil. — Stock Photo
    Illustration of a neutrophil.
    Digital illustration of cloud of antibodies on white background. — Stock Photo
    Digital illustration of cloud of antibodies on white background.
    Antibodies binding influenza virus. Illustration of human antibodies (orange) neutralizing a influenza virus particle (blue). Each Y-shaped molecule has two arms that can bind to specific antigens — Stock Photo
    Antibodies binding influenza virus. Illustration of human antibodies (orange) neutralizing a influenza virus particle (blue). Each Y-shaped molecule has two arms that can bind to specific antigens
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center) — Stock Photo
    Illustration of antibodies (purple) responding to an infection with the SARS-CoV-2 coronavirus (center)
    3d illustration of antibodies attacking virus particles. — Stock Photo
    3d illustration of antibodies attacking virus particles.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with RNA (ribonucleic acid, blue helix) vaccine. viral proteins will provoke immune response, priming body against infection — Stock Photo
    RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with RNA (ribonucleic acid, blue helix) vaccine. viral proteins will provoke immune response, priming body against infection
    Digital artwork of white blood cells attacking red illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking red illuminated cancer cell.
    Colored scanning electron micrograph of protective dendritic cell of immune system. — Stock Photo
    Colored scanning electron micrograph of protective dendritic cell of immune system.
    Digital artwork of white blood cells attacking illuminated cancer cell. — Stock Photo
    Digital artwork of white blood cells attacking illuminated cancer cell.
    Digital artwork of T-lymphocyte cells attacking red cancer cell. — Stock Photo
    Digital artwork of T-lymphocyte cells attacking red cancer cell.
    Lassa virus particles, digital illustration. — Stock Photo
    Lassa virus particles, digital illustration.
    Immune system T-lymphocytes cells binding antigen, digital illustration. — Stock Photo
    Immune system T-lymphocytes cells binding antigen, digital illustration.